An immunoblot technology platform for protein detection and analysis in clinical diagnostics. The system utilizes antibody-based detection methods for identification of specific antigens in patient samples.
Manufactured by
Shenzhen, China
Founded in 2008, Shenzhen YHLO Biotech Co., Ltd. (YHLO) is a publicly listed company on the Science and Technology Innovation Board (stock code: 688575). Based in Shenzhen, YHLO excels in the research, development, production, sales, and service of in vitro diagnostic (IVD) products. Recognized as a national high-tech enterprise with extensive independent intellectual property rights, YHLO has earned numerous accolades, including being named a National Intellectual Property Demonstration Enterprise and one of Shenzhen's Top 70 Innovative Enterprises. YHLO utilizes six advanced IVD technology platforms, including chemiluminescence, biochemistry, indirect immunofluorescence, immunoblotting, fluorescent immunochromatography, and colloidal gold immunochromatography. With a portfolio of over 300 products addressing areas such as autoimmunity, reproductive health, infection, liver disease, and respiratory diseases, YHLO's products are widely implemented across hospitals, community clinics, and third-party testing centers, with a coverage rate exceeding 70% in China's top-tier hospitals. While firmly rooted in the domestic market, YHLO actively expands its international presence, with products exported to nearly 115 countries and regions, gaining recognition and trust from global customers. YHLO has made substantial investments in research and development, establishing research centers in Tokyo, Japan; Wuhan, China; and Changsha, China, as well as setting up a production base in Xiangtan, China. As of August 30, 2024, the company has filed for 681 patents, including 58 PCT patents, 367 invention patents, 167 utility model patents, and 22 design patents. YHLO prioritizes the integration of industry, academia, and research, establishing collaborative laboratories with prestigious institutions such as Peking University, the Institute of Biophysics of the Chinese Academy of Sciences, the Chinese University of Hong Kong (Shenzhen), the Southern University of Science and Technology, the Third People's Hospital of Shenzhen, Huazhong University of Science and Technology, and the National Innovation Center for High-Performance Medical Devices. YHLO adheres to the mission of Focus on healthcare, better life with technology, consistently striving for excellence and delivering outstanding products and services for human health, with the goal of being a leading enterprise in the life sciences and a global leader in in vitro diagnostics.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Guangzhou Wondfo Biotech Co., Ltd.
China · 1 relevant product
ReLIA Bioengineering(Jiangsu), Inc
China · 1 relevant product
S&T BioMed CO., LTD.
Taiwan · 1 relevant product
Excélsior Bio-System Incorporation
Taiwan · 1 relevant product
Suzhou hybiome biomedical engineering Co.ltd
China · 1 relevant product
ZIODIA Co., Ltd.
South Korea · 1 relevant product
Shenzhen Homed Medical Device Co., Ltd.
China · 1 relevant product
Jiangsu Sunlant Bioengineering Co., Ltd.
China · 1 relevant product
Shanghai Beion Medical Technology Co.,LTD.
China · 2 relevant products
guangzhou biotron technolongy co.,ltd
China · 1 relevant product
29 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 43 closest product alternatives
Guangzhou Wondfo Biotech Co., Ltd. · China
Immunofluorescence-based diagnostic platform for detection and identification of specific antigens or antibodies in clinical samples. Provides fluorescence-based results for rapid point-of-care and laboratory testing.
ReLIA Bioengineering(Jiangsu), Inc · China
A diagnostic platform for point-of-care testing (POCT) that uses immunofluorescence technology for rapid and accurate detection. The platform features precise temperature control, multiple connectivity options, and automatic sample identification to enable quick diagnostic testing.
S&T BioMed CO., LTD. · Taiwan
Automated immunoassay system utilizing electrochemical detection methods for biomarker quantification. Suitable for high-throughput clinical laboratory applications.
Excélsior Bio-System Incorporation · Taiwan
Proprietary microarray technology platform for immunological testing and allergen detection. Enables high-throughput analysis of biological markers in clinical diagnostics.
Suzhou hybiome biomedical engineering Co.ltd · China
Automated system for blood group and antibody identification testing. Integrated platform for immunohematology analysis in clinical laboratories.
ZIODIA Co., Ltd. · South Korea
A diagnostic device platform based on MEMS (Micro-Electro-Mechanical System) core technology that enables precise control and detection of minute whole blood samples and implements real-time analysis at the point-of-care level through Lab-on-a-Chip technology. The platform is designed for medical chain diagnosis devices and related solutions.
Shenzhen Homed Medical Device Co., Ltd. · China
In vitro diagnostic testing platform for clinical laboratory analysis. Supports disease screening and monitoring across multiple therapeutic areas.
Jiangsu Sunlant Bioengineering Co., Ltd. · China
A microarray-based chemiluminescence immunoassay platform using hard-substrate glass slides as carriers with covalently bound monoclonal antibodies. The platform features integrated positive and negative quality control points, multi-parameter detection with up to 56 array points, and a sandwich immunoassay methodology. It combines high-sensitivity chemiluminescence detection with high-throughput biochip technology using an integrated photoelectric sensor to read all signal points simultaneously.
Shanghai Beion Medical Technology Co.,LTD. · China
Immunological analysis platform for detection of antigens and antibodies in clinical samples. Supports various immunoassay methods for comprehensive immune system evaluation.
guangzhou biotron technolongy co.,ltd · China
Point-of-care testing platform based on immunochemical principles for rapid on-site diagnostic testing without laboratory infrastructure requirements.
Biosino Bio-Technology and Science Inc. · China
In-vitro diagnostic products for immunological analysis and testing, supporting comprehensive serological and immunological assessments in clinical laboratories. Part of the company's integrated diagnostic platform.
EUROIMMUN · United States
Immunoblot technology for protein detection and analysis in diagnostic testing. Used in autoimmunity and infection disease diagnostics.
31 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products